ASPM expression did not differ between astrocytic (2 AII, 36 AIII), oligodendroglial (1 OII, 13 OIII) or mixed glioma samples (5 OAII, 26 OA III) (Figure 1a). This evidence concerns the gene ASPM and central nervous system cancer.